A detailed history of Cresset Asset Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 18,176 shares of OGN stock, worth $267,732. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,176
Previous 18,340 0.89%
Holding current value
$267,732
Previous $379,000 8.44%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.65 - $23.03 $3,058 - $3,776
-164 Reduced 0.89%
18,176 $347,000
Q2 2024

Aug 14, 2024

BUY
$17.45 - $21.96 $5,304 - $6,675
304 Added 1.69%
18,340 $379,000
Q1 2024

May 15, 2024

SELL
$13.78 - $18.8 $6,821 - $9,306
-495 Reduced 2.67%
18,036 $339,000
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $48,858 - $77,281
4,462 Added 31.72%
18,531 $267,000
Q3 2023

Nov 14, 2023

BUY
$16.59 - $23.77 $32,947 - $47,207
1,986 Added 16.44%
14,069 $244,000
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $232,839 - $297,604
12,083 New
12,083 $251,000
Q4 2022

Feb 14, 2023

SELL
$23.31 - $28.61 $15,664 - $19,225
-672 Reduced 4.3%
14,947 $417,000
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $9,594 - $14,042
-410 Reduced 2.56%
15,619 $365,000
Q2 2022

Aug 15, 2022

BUY
$31.66 - $38.9 $65,219 - $80,134
2,060 Added 14.75%
16,029 $538,000
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $15,011 - $19,404
493 Added 3.66%
13,969 $488,000
Q4 2021

Feb 10, 2022

SELL
$28.67 - $37.13 $105,648 - $136,824
-3,685 Reduced 21.47%
13,476 $410,000
Q3 2021

Nov 15, 2021

BUY
$28.63 - $35.64 $6,040 - $7,520
211 Added 1.24%
17,161 $563,000
Q2 2021

Aug 10, 2021

BUY
$28.45 - $38.0 $482,227 - $644,100
16,950 New
16,950 $513,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.